(NP (NP (JJ Nuclear) (NN factor) (NN kappa) (NN B)) (, ,) (NP (NP (DT a) (NN mediator)) (PP (IN of) (NP (NN lipopolysaccharide) (NNS effects)))) (. .))
(S (NP-SBJ (NP (NN Exposure)) (PP (IN of) (NP (JJ certain) (NN cell) (NNS types))) (PP (TO to) (NP (JJ bacterial) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ inducible) (NN transcription) (NN factor))))))) (. .))
(S (NP-SBJ (NP (CD One)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B) (POS 's)) (JJ unique) (NNS properties)))) (VP (VBZ is) (NP-PRD (NP (PRP$ its) (JJ posttranslational) (NN activation)) (PP (IN via) (NP (NP (NN release)) (PP (IN of) (NP (NP (DT an) (JJ inhibitory) (NN subunit)) (, ,) (VP (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NP (NP (NN inhibitor)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (PRN (-LRB- -LRB-) (NP (NN I) (NN kappa) (NN B)) (-RRB- -RRB-))))) (, ,))) (PP (IN from) (NP (DT a) (JJ sequestered) (JJ cytoplasmic) (NN form))))))) (. .))
(S (NP-SBJ-48 (DT This) (NN event)) (VP (VBZ is) (VP (ADVP (RB also)) (VBN triggered) (NP (-NONE- *-48)) (PP (IN under) (NP (NP (JJ various) (JJ other) (NNS conditions)) (PP (IN of) (NP (JJ biomedical) (NN importance))))))) (. .))
(S (NP-SBJ-COOD-49 (NP (JJ Other) (JJ bacterial) (NNS toxins)) (, ,) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (, ,) (NP (NP (NN interleukin-1)) (PRN (-LRB- -LRB-) (NP (NN IL-1)) (-RRB- -RRB-))) (, ,) (NP (NN T) (NN cell) (NNS mitogens)) (, ,) (NP (NN UV) (NN light)) (, ,) (NP (NN gamma) (NNS rays)) (CC and) (NP (JJ oxidative) (NN stress))) (VP (VBD were) (VP (VBN reported) (S (NP-SBJ (-NONE- *-49)) (VP (TO to) (VP (VB induce) (NP (NN NF-kappa) (NN B))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ activated) (NN form)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (, ,) (SBAR (WHNP-50 (WDT which)) (S (NP-SBJ-51 (-NONE- *T*-50)) (VP (VBZ is) (VP (ADVP-TMP (RB rapidly)) (VBN taken) (PRT (RP up)) (NP (-NONE- *-51)) (PP (IN into) (NP (NNS nuclei))))))) (, ,)) (VP (VBZ initiates) (NP (NP (NN transcription)) (PP (IN from) (NP (JJ immediate) (JJ early) (NNS genes))) (PP (IN in) (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NN cell) (NNS types))))))) (. .))
(S (NP-SBJ-52 (NP (JJS Most)) (PP (IN of) (NP (NP (DT the) (NN target) (NNS genes)) (PP (IN for) (NP (NN NF-kappa) (NN B)))))) (VP-COOD (VP (VBP are) (PP-PRD (IN of) (NP (NN relevance))) (PP (IN for) (NP (DT the) (JJ immune) (NN response)))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN grouped) (NP (-NONE- *-52)) (PP (IN into) (NP (NP (DT those)) (VP (JJ encoding) (NP-COOD (NP (NNS cytokines)) (, ,) (NP (NN cell) (NN surface) (NNS receptors)) (, ,) (NP (JJ acute) (NN phase) (NNS proteins)) (CC and) (NP (JJ viral) (NNS genomes)))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (MD will) (VP (VB discuss) (NP (NP (JJ recent) (JJ experimental) (NNS evidences)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN LPS)) (VP (MD might) (VP (VB share) (NP (NP (DT a) (NN pathway)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN activation)))) (PP (IN with) (NP (NP (JJ other) (NNS inducers)) (PP (IN of) (NP (DT the) (NN factor))))))))))))) (. .))
(S (NP-SBJ (DT This) (JJ common) (NN pathway)) (VP (MD may) (VP (VB involve) (NP (NP (JJ reactive) (NN oxygen) (NNS intermediates)) (PRN (-LRB- -LRB-) (NP (NN ROI)) (-RRB- -RRB-))) (PP (IN as) (NP (NN messenger) (NNS molecules))))) (. .))
